“India will not compromise on drug licensing norms and [will] continue to produce generic drugs for free treatment to HIV-positive patients, Commerce and Industry Minister Anand Sharma said” on Wednesday, the IANS/Times of India reports.
Access to Health Services
In another installment in NPR’s summer-long series “Beginnings,” NPR’s All Things Considered aired a story on Wednesday examining how the controversial drug misoprostol is being used worldwide to save women’s lives.
“Cash-strapped Swaziland’s state hospitals have only two months’ supplies of AIDS drugs, the country’s health minister has told parliament in an assessment that AIDS patients and activists took as a death sentence,” the Associated Press/Seattle Times reports. More than 60,000 Swazis receive antiretroviral medicine at no cost from state-run hospitals.
“Long heralded as a model for the global response to HIV/AIDS, Brazil is intensifying its actions, at home and abroad, in the face of potential setbacks including an arising need for new treatment regimens, the resultant increase in drug prices and the debate over intellectual property rights,” Inter Press Service…
GlobalPost on Sunday published two articles examining family planning and maternal mortality in Malawi.
Family planning “is one of the most cost-effective ways to prevent illness and save lives in the world’s poor countries,” according to health experts gathered in Addis Ababa, Ethiopia, at a conference sponsored by the Reproductive Health Supplies Coalition, GlobalPost’s “Africa Emerges” blog reports.
The social entrepreneurial organization Ashoka and pharmaceutical company Boehringer Ingelheim on Tuesday announced they are launching a three-year global initiative aimed at “promot[ing] healthy individuals, families and communities by identifying and supporting the most promising solutions to challenging health problems,” according to an Ashoka press release. The “Making More Health”…
As Tachi Yamada, president of global health at the Bill & Melinda Gates Foundation, prepares to leave the foundation this month, Nature News interviewed him about his work at the Gates Foundation and his predictions for global health.
After serving as “a lifeline to poor countries, supplying HIV drugs that have saved millions of lives â€¦ [n]ow India is aiming to become a drugs factory for rich countries such as Japan,” which is looking to use more generic drugs in an effort to slow rising health care costs, Nature News reports.
“Access to treatment for drug-resistant tuberculosis (DR-TB) remains compromised, especially in developing countries, because too few pharmaceutical companies manufacture quality-assured drugs,” Inter Press Service reports in an article examining how a lack of competition and a working mechanism to keep prices low “has led to skyrocketing prices.”